Molecular genetics in the pediatric intensive care unit

Critical Care Clinics

Volumn 19, Issue 3, 2003, Pages 577-594

  Shanley, Thomas P ^a,b   Wong, Hector R ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESTRICTION ENDONUCLEASE;

CRITICAL ILLNESS; DIAGNOSTIC TEST; DNA MICROARRAY; GENE STRUCTURE; GENETIC POLYMORPHISM; GENOMICS; HERPES SIMPLEX VIRUS; HUMAN; INTENSIVE CARE; LUNG INJURY; MEDICAL TECHNOLOGY; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SEPSIS; SEPTIC SHOCK; VIRUS DETECTION;

EID: 0037968646     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(03)00004-6     Document Type: Review

References (79)

1. Wong HR, Shanley TP. Signal transduction pathways in acute lung injury: NF-κB and AP-1. In: Wong HR, Shanley TP, editors. Molecular biology of acute lung injury. Norwell (MA): Kluwer Academic Publishers; 2001. p. 1-16.
2. Crawford EK, Ensor JE, Kalvakolanu I, et al. The role of 3′ poly(A) tail metabolism in tumor necrosis factor-alpha regulation. J Biol Chem 1997;272:21120.
3. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999;1:3.
4. Giordano M, Mellai M, Hoogendoom B, et al. Determination of SNP allele frequencies in pooled DNAs by primer extension genotyping and denaturing high-performance liquid chromatography. J Biochem Biophys Methods 2001;47:101.
5. Germer S, Holland MJ, Higuchi R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 2000;10:258.
6. Hayashi K, Wenz HM, Inazuka M, et al. SSCP analysis of point mutations by multicolor capillary electrophoresis. Methods Mol Biol 2001;163:109.
7. Sasaki T, Tahira T, Suzuki A, et al. Precise estimation of allele frequencies of single-nucleotide polymorphisms by a quantitative SSCP analysis of pooled DNA. Am J Hum Genet 2001;68:214.
8. Buetow KH, Edmonson M, MacDonald R, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 2001;98:581.
9. Ross P, Hall L, Haff LA. Quantitative approach to single-nucleotide polymorphism analysis using MALDI-TOF mass spectrometry. Biotechniques 2000;29:620.
10. Werner M, Sych M, Herbon N, et al. Large-scale determination of SNP allele frequencies in DNA pools using MALDI-TOF mass spectrometry. Hum Mutat 2002;20:57.
11. Rowley AH, Whitley RJ, Lakeman FD, et al. Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet 1990;335:440.
12. Pauschinger M, Doerner A, Kuehl U, et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 1999;99:889.
13. Chung TP, Laramie JM, Province M, et al. Functional genomics of critical illness and injury. Crit Care Med 2002;30:S51.
14. Jordan BR, 'Genomics': buzzword or reality? J Biomed Sci 1999;6:145.
15. Peltonen L, McKusick VA. Genomics and medicine. Dissecting human disease in the postgenomic era. Science 2001;291:1224.
16. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860.
17. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304.
18. Kawai J, Shinagawa A, Shibata K, et al. Functional annotation of a full-length mouse cDNA collection. Nature 2001;409:685.
19. Watanabe TK, Bihoreau MT, McCarthy LC, et al. A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet 1999;22:27.
20. Adams MD, Celniker SE, Holt RA, et al. The genome sequence of Drosophila melanogaster. Science 2000;287:2185.
21. Parkhill J, Achtman M, James KD, et al. Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 2000;404:502.
22. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 2000;406:959.
23. Kaminski N. Bioinformatics. A user's perspective. Am J Respir Cell Mol Biol 2000;23:705.
24. Roos DS. Computational biology. Bioinformatics-trying to swim in a sea of data. Science 2001;291:1260.
25. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286:487.
26. Kalow W. Perspectives in pharmacogenetics. Arch Pathol Lab Med 2001;125:77.
27. Fox MH, Hunt PC. Prolonged neuromuscular block associated with mivacurium. Br J Anaesth 1995;74:237.
28. Robertson GS. Serum cholinesterase deficiency. I. Disease and inheritance. Br J Anaesth 1966;38:355.
29. Desmeules J, Gascon MP, Dayer P, et al. Impact of environmental and genetic factors on codeine analgesia. Eur J Clin Pharmacol 1991;41:23.
30. Sindrup SH, Brosen K. The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics 1995;5:335.
31. Liggett SB. Genetics of beta 2-adrenergic receptor variants in asthma. Clin Exp Allergy 1995;25(Suppl 2):89.
32. Martinez FD, Graves PE, Baldini M, et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184.
33. Reihsaus E, Innis M, MacIntyre N, et al. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334.
34. Emilien G, Ponchon M, Caldas C, et al. Impact of genomics on drug discovery and clinical medicine. QJM 2000;93:391.
35. DeRisi JL, Iyer VR. Genomics and array technology. Curr Opin Oncol 1999;11:76.
36. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000;405:827.
37. Fodor SP, Rava RP, Huang XC, et al. Multiplexed biochemical assays with biological chips. Nature 1993;364:555.
38. Fodor SP, Read JL, Pirrung MC, et al. Light-directed, spatially addressable parallel chemical synthesis. Science 1991;251:767.
39. Lipshutz RJ, Morris D, Chee M, et al. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 1995;19:442.
40. Pease AC, Solas D, Sullivan EJ, et al. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci U S A 1994;91:5022.
41. Lennon GG, Lehrach H. Hybridization analyses of arrayed cDNA libraries. Trends Genet 1991;7:314.
42. Alon U, Barkai N, Notterman DA, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A 1999;96:6745.
43. Sgroi DC, Teng S, Robinson G, et al. In vivo gene expression profile analysis of human breast cancer progression. Cancer Res 1999;59:5656.
44. Wiegand G, Selleng K, Grundling M, et al. Gene expression pattern in human monocytes as a surrogate marker for systemic inflammatory response syndrome (SIRS). Mol Med 1999;5:192.
45. McDowell SA, Gammon K, Bachurski CJ, et al. Differential gene expression in the initiation and progression of nickel-induced acute lung injury. Am J Respir Cell Mol Biol 2000;23:466.
46. Nadadur SS, Schladweiler MC, Kodavanti UP. A pulmonary rat gene array for screening altered expression profiles in air pollutant-induced lung injury. Inhal Toxicol 2000;12:1239.
47. Lyn D, Liu X, Bennett NA, et al. Gene expression profile in mouse myocardium after ischemia. Physiol Genomics 2000;2:93.
48. Sehl PD, Tai JT, Hillan KJ, et al. Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 2000;101:1990.
49. Cobb JP, Brownstein BH, Watson MA, et al. Injury in the era of genomics. Shock 2001;15:165.
50. Cahill DJ. Protein and antibody arrays and their medical applications. J Immunol Methods 2001;250:81.
51. Fung ET, Wright Jr. GL, Dalmasso EA. Proteomic strategies for biomarker identification: progress and challenges. Curr Opin Mol Ther 2000;2:643.
52. Leikauf GD, McDowell SA, Wesselkamper SC, et al. Acute lung injury: functional genomics and genetic susceptibility. Chest 2002;121:70S.
53. Leikauf GD, McDowell SA, Bachurski CJ, et al. Functional genomics of oxidant-induced lung injury. Adv Exp Med Biol 2001;500:479.
54. Olman MA, White KE, Ware LB, et al. Microarray analysis indicates that pulmonary edema fluid from patients with acute lung injury mediates inflammation, mitogen gene expression, and fibroblast proliferation through bioactive interleukin-1. Chest 2002;121:69S.
55. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343.
56. Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:646.
57. Ortiz LA, Champion HC, Lasky JA, et al. Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappaB and AP-1. Am J Physiol Lung Cell Mol Physiol 2002;282:L1209.
58. Albelda SM. Pulmonary genetics, genomics, and gene therapy: conference summary. Chest 2002;121:105S.
59. Nomura F, Akashi S, Sakao Y, et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000;164:3476.
60. Qureshi ST, Lariviere L, Leveque G, et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999;189:615.
61. Medzhitov R, Preston-Hurlburt P, Janeway Jr. CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394.
62. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187.
63. Lorenz E, Mira JP, Cornish KL, et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68:6398.
64. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355.
65. Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999;282:561.
66. Stuber F, Udalova IA, Book M, et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1995;46:42.
67. Bogardus Jr. ST, Concato J, Feinstein AR. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA 1999;281:1919.
68. Westendorp RG, Langermans JA, de Bel CE, et al. Release of tumor necrosis factor: an innate host characteristic that may contribute to the outcome of meningococcal disease. J Infect Dis 1995;171:1057.
69. Donnelly SC, Strieter RM, Reid PT, et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 1996;125:191.
70. Eskdale J, Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995;42:444.
71. Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998;95:9465.
72. Eskdale J, McNicholl J, Wordsworth P, et al. lnterleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998;352:1282.
73. Suzuki T, Hashimoto S, Toyoda N, et al. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 2000;96:2584.
74. Fessler MB, Malcolm KC, Duncan MW, et al. Lipopolysaccharide stimulation of the human neutrophil: an analysis of changes in gene transcription and protein expression by oligonucleotide microarrays and proteomics. Chest 2002;121:75S.
75. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699.
76. Joyce DE, Gelbert L, Ciaccia A, et al. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001;276:11199.
77. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, et al. Molecular signatures of sepsis: multi-organ gene expression profiles of systemic inflammation. Am J Pathol 2001;159:1199.
78. Mahan MJ, Heithoff DM, Sinsheimer RL, et al. Assessment of bacterial pathogenesis by analysis of gene expression in the host. Annu Rev Genet 2000;34:139.
79. Ichikawa JK, Norris A, Bangera MG, et al. Interaction of pseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. Proc Natl Acad Sci U S A 2000;97:9659.